Skip to main content
Medrx Co.,Ltd. logo

Medrx Co.,Ltd. — Investor Relations & Filings

Ticker · 4586 ISIN · JP3921220004 T Manufacturing
Open in API
Filings indexed 79 across all filing types
Latest filing 2022-03-31 Annual Report
Country JP Japan
Listing T 4586

About Medrx Co.,Ltd.

https://www.medrx.co.jp/english/

Medrx Co., Ltd. is a pharmaceutical formulation development company that specializes in creating new dosage forms of medicines. The company's core focus is its transdermal absorption technology, which is used to develop innovative drug delivery systems like patches. These products are designed to improve patient health and quality of life (QOL) by providing alternatives for medications that are difficult to administer orally or by helping to prevent patients from forgetting to take their medicine. Medrx is actively engaged in research and development, managing a pipeline of pharmaceutical candidates that utilize its proprietary formulation technologies.

Recent filings

Filing Released Lang Actions
有価証券報告書－第20期(令和3年1月1日－令和3年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard annual securities report required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains detailed financial statements, business descriptions, and management analysis for the fiscal year ending December 31, 2021. This corresponds to the 10-K equivalent in the Japanese regulatory framework. FY 2021
2022-03-31 Japanese
四半期報告書－第20期第3四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and share information for the third quarter of the 20th fiscal period (July 1, 2021, to September 30, 2021). As it is a comprehensive financial report for an interim period containing actual financial data, it is classified as an Interim/Quarterly Report. 9M 2021
2021-11-12 Japanese
四半期報告書－第20期第2四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and business updates for the second quarter of the 20th fiscal period (April 1, 2021, to June 30, 2021). This fits the definition of an Interim/Quarterly Report (IR). Q2 2021
2021-08-11 Japanese
有価証券届出書（組込方式）
Share Issue/Capital Change Classification · 95% confidence The document is a 'Securities Registration Statement' (有価証券届出書) filed with the Kanto Local Finance Bureau by Medrx Co., Ltd. on May 18, 2021. It details the issuance of new stock acquisition rights (第20回新株予約権 and 第21回新株予約権). This type of filing is a regulatory document concerning capital structure and financing activities, which falls under the 'Capital/Financing Update' category.
2021-05-18 Japanese
訂正四半期報告書－第19期第3四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Medrx Co., Ltd. covering the third quarter of the 19th fiscal period (July 1, 2020, to September 30, 2020). It contains detailed financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). Q3 2020
2021-05-18 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO and CFO regarding the accuracy of a previously filed Annual Securities Report (Yuuka Shouken Houkokusho). Since it is a regulatory filing confirming the validity of financial disclosures and does not fit into the specific categories of financial reports, audit reports, or announcements, it is best classified as a general Regulatory Filing (RNS). FY 2020
2021-05-18 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.